Clinical, molecular, and environmental risk factors for Hodgkin lymphoma

Advances in Hematology

Volumn 2011, Issue , 2011, Pages

  Flowers, Christopher R ^a   Maggioncalda, Alison ^a   Malik, Neha ^a   Shenoy, Pareen ^a   Smith, Melody ^a   Sinha, Rajni ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; INTERLEUKIN 12;

ALCOHOL CONSUMPTION; CANADA; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER RISK; COMORBIDITY; ENVIRONMENTAL FACTOR; EPSTEIN BARR VIRUS; ETHNICITY; EXERCISE; GENETIC RISK; GENETIC VARIABILITY; HODGKIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE RESPONSE; ISRAEL; MOLECULAR BIOLOGY; OCCUPATIONAL EXPOSURE; PHENOTYPE; PRIORITY JOURNAL; RACE DIFFERENCE; REVIEW; SINGAPORE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SOCIAL ENVIRONMENT; SOCIOECONOMICS; TH2 CELL; UNITED KINGDOM; UNITED STATES;

EID: 79251557457     PISSN: 16879104     EISSN: 16879112     Source Type: Journal    
DOI: 10.1155/2011/736261     Document Type: Review

References (57)

1. Rosenberg S. A., Kaplan H. S., Evidence for an orderly progression in the spread of Hodgkin's disease Cancer Research 1966 26 6 1225 1231
2. Glaser S. L., Clarke C. A., Gulley M. L., Craig F. E., DiGiuseppe J. A., Dorfman R. F., Mann R. B., Ambinder R. F., Population-based patterns of human immunodeficiency virus-related Hodgkin lymphoma in the greater San Francisco bay area, 19881998 Cancer 2003 98 2 300 309
3. American Cancer Society,. Cancer Facts Figures, 2010
4. Altekruse S., Kosary C., Krapcho M., SEER Cancer Statistics Review 2010 Bethesda, Md, USA National Cancer Institute
5. Punnett A., Tsang R. W., Hodgson D. C., Hodgkin lymphoma across the age spectrum: epidemiology, therapy, and late effects Seminars in Radiation Oncology 2010 20 1 30 44
6. Schnitzer B., Hodgkin lymphoma Hematology/Oncology Clinics of North America 2009 23 4 747 768
7. Kppers R., The biology of Hodgkin's lymphoma Nature Reviews Cancer 2009 9 1 15 27
8. Aldred V., Vassallo J., Froes M. Campos A. H. J., Augusto Soares F., CD20 expression by Hodgkin-Reed-Sternberg cells in classical Hodgkin lymphoma is related to reduced overall survival in young adult patients Leukemia and Lymphoma 2008 49 11 2198 2202
9. Mathas S., Janz M., Hummel F., Hummel M., Wollert-Wulf B., Lusatis S., Anagnostopoulos I., Lietz A., Sigvardsson M., Jundt F., Jhrens K., Bommert K., Stein H., Drken B., Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma Nature Immunology 2006 7 2 207 215
10. Kppers R., Klein U., Schwering I., Distler V., Bruninger A., Cattoretti G., Tu Y., Stolovitzky G. A., Califano A., Hansmann M.-L., Dalla-Favera R., Identification of Hodgkin and Reed-Sternberg cell-specific genes by gene expression profiling Journal of Clinical Investigation 2003 111 4 529 537
11. Renn C., Martin-Subero J. I., Eickernjger M., Hansmann M.-L., Kppers R., Siebert R., Bruninger A., Aberrant expression of ID2, a suppressor of B-cell-specific gene expression, in Hodgkin's lymphoma American Journal of Pathology 2006 169 2 655 664
12. Foss H.-D., Reusch R., Demel G., Lenz G., Anagnostopoulos I., Hummel M., Stein H., Frequent expression of the B-cell-specific activator protein in Reed- Sternberg cells of classical Hodgkin's disease provides further evidence for its B-cell origin Blood 1999 94 9 3108 3113
13. Hoppe R. T., Ranjana H. A., Weiyun Z. A., Hodgkin lymphoma NCCN Clinical Practice Guidelines in Oncology 2010 1 47
14. Devita V. T. Jr. , Serpick A. A., Carbone P. P., Combination chemotherapy in the treatment of advanced Hodgkin's disease Annals of Internal Medicine 1970 73 6 881 895
15. Macmahon B., Epidemiological evidence of the nature of Hodgkin's disease Cancer 1957 10 5 1045 1054
16. Hjalgrim H., Seow A., Rostgaard K., Friborg J., Changing patterns of Hodgkin lymphoma incidence in Singapore International Journal of Cancer 2008 123 3 716 719
17. Pahwa P., Karunanayake C. P., Spinelli J. J., Dosman J. A., McDuffie H. H., Ethnicity and incidence of Hodgkin lymphoma in Canadian population BMC Cancer 2009 9, article 141
18. Chang E. T., Zheng T., Weir E. G., Borowitz M., Mann R. B., Spiegelman D., Mueller N. E., Childhood social environment and Hodgkin's lymphoma: new findings from a population-based case-control study Cancer Epidemiology Biomarkers and Prevention 2004 13 8 1361 1370
19. Karunanayake C. P., Singh G. V., Spinelli J. J., McLaughlin J. R., Dosman J. A., McDuffie H. H., Pahwa P., Occupational exposures and hodgkin lymphoma: Canadian case-control study Journal of Occupational and Environmental Medicine 2009 51 12 1447 1454
20. Cozen W., Hamilton A. S., Zhao P., Salam M. T., Deapen D. M., Nathwani B. N., Weiss L. M., Mack T. M., A protective role for early oral exposures in the etiology of young adult Hodgkin lymphoma Blood 2009 114 19 4014 4020
21. Glaser S. L., Keegan T. H. M., Clarke C. A., Darrow L. A., Gomez S. L., Dorfman R. F., Mann R. B., DiGiuseppe J. A., Ambinder R. F., Smoking and Hodgkin lymphoma risk in women United States Cancer Causes and Control 2004 15 4 387 397
22. Keegan T. H. M., Glaser S. L., Clarke C. A., Dorfman R. F., Mann R. B., DiGiuseppe J. A., Chang E. T., Ambinder R. F., Body size, physical activity, and risk of Hodgkin's lymphoma in women Cancer Epidemiology Biomarkers and Prevention 2006 15 6 1095 1101
23. Chang E. T., Cronin-Fenton D. P., Friis S., Hjalgrim H., Srensen H. T., Pedersen L., Aspirin and other nonsteroidal anti-inflammatory drugs in relation to Hodgkin lymphoma risk in Northern Denmark Cancer Epidemiology Biomarkers and Prevention 2010 19 1 59 64
24. Briggs N. C., Irene Hall H., Brann E. A., Moriarty C. J., Levine R. S., Cigarette smoking and risk of Hodgkin's disease: a population-based case-control study American Journal of Epidemiology 2002 156 11 1011 1020
25. Chang E. T., Birmann B. M., Kasperzyk J. L., Conti D. V., Kraft P., Ambinder R. F., Zheng T., Mueller N. E., Polymorphic variation in NFKB1 and other aspirin-related genes and risk of Hodgkin lymphoma Cancer Epidemiology Biomarkers and Prevention 2009 18 3 976 986
26. Mollaki V., Georgiadis T., Tassidou A., Ioannou M., Daniil Z., Koutsokera A., Papathanassiou A. A., Zintzaras E., Vassilopoulos G., Polymorphisms and haplotypes in TLR9 and MYD88 are associated with the development of Hodgkin's lymphoma: a candidate-gene association study Journal of Human Genetics 2009 54 11 655 659
27. Ariad S., Lipshitz I., Benharroch D., Gopas J., Barchana M., A sharp rise in the incidence of Hodgkin's lymphoma in young adults in Israel Israel Medical Association Journal 2009 11 8 453 455
28. Levy A., Diomin V., Gopas J., Ariad S., Sacks M., Benharroch D., Hodgkin's lymphoma in the Bedouin of southern Israel: epidemiological and clinical features Israel Medical Association Journal 2000 2 7 501 503
29. Pinheiro G. S., Silva M. R. R., Rodrigues C. A., Kerbauy J., de Oliveira J. S. R., Proliferating cell nuclear antigen (PCNA), p53 and MDM2 expression in Hodgkins disease Sao Paulo Medical Journal 2007 125 2 77 84
30. Glaser S. L., Hsu J. L., Hodgkin's disease in Asians: incidence patterns and risk factors in population-based data Leukemia Research 2002 26 3 261 269
31. Flavell K. J., Biddulph J. P., Powell J. E., Parkes S. E., Redfern D., Weinreb M., Nelson P., Mann J. R., Young L. S., Murray P. G., South Asian ethnicity and material deprivation increase the risk of Epstein-Barr virus infection in childhood Hodgkin's disease British Journal of Cancer 2001 85 3 350 356
32. Phillimore P., Beattie A., Townsend P., Widening inequality of health in northern England, 198191 British Medical Journal 1994 308 6937 1125 1128
33. Roswall N., Olsen A., Christensen J., Rugbjerg K., Mellemkjr L., Social inequality and incidence of and survival from Hodgkin lymphoma, non-Hodgkin lymphoma and leukaemia in a population-based study in Denmark, 19942003 European Journal of Cancer 2008 44 14 2058 2073
34. Soares A., Biasoli I., Scheliga A., Luiz R. R., Costa M. A., Land M., Romano S., Morais J. C., Spector N., Socioeconomic inequality and short-term outcome in Hodgkin's lymphoma International Journal of Cancer 2007 120 4 875 879
35. Martinez F. D., Holt P. G., Role of microbial burden in aetiology of allergy and asthma Lancet 1999 354 2 SII12 SII15
36. Matricardi P. M., Bonini S., High microbial turnover rate preventing atopy: a solution to inconsistencies impinging on the Hygiene hypothesis? Clinical and Experimental Allergy 2000 30 11 1506 1510
37. Skinnider B. F., Mak T. W., The role of cytokines in classical Hodgkin lymphoma Blood 2002 99 12 4283 4297
38. Amlot P. L., Green L. A., Atopy and immunoglobulin E concentrations in Hodgkin's disease and other lymphomas British Medical Journal 1978 1 6109 327 329
39. Mack T. M., Deapen D., Hamilton A. S., Representativeness of a roster of volunteer North American twins with chronic disease Twin Research 2000 3 1 33 42
40. Gunnell D., Height, insulin-like growth factors and cancer risk Growth Hormone and IGF Research 2000 10 S39 S40
41. Monnereau A., Orsi L., Troussard X., Berthou C., Fenaux P., Soubeyran P., Marit G., Huguet F., Milpied N., Leporrier M., Hemon D., Clavel J., Cigarette smoking, alcohol drinking, and risk of lymphoid neoplasms: Results of a French case-control study Cancer Causes and Control 2008 19 10 1147 1160
42. Ambinder R. F., Epstein-barr virus and hodgkin lymphoma Hematology 2007 204 209
43. Glaser S. L., Lin R. J., Stewart S. L., Ambinder R. F., Jarrett R. F., Brousset P., Pallesen G., Gulley M. L., Khan G., O'Grady J., Hummel M., Preciado M. V., Knecht H., Chan J. K. C., Claviez A., Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data International Journal of Cancer 1997 70 4 375 382
44. Crawford D. H., Macsween K. F., Higgins C. D., Thomas R., McAulay K., Williams H., Harrison N., Reid S., Conacher M., Douglas J., Swerdlow A. J., A cohort study among university students: identification of risk factors for Epstein-Barr virus seroconversion and infectious mononucleosis Clinical Infectious Diseases 2006 43 3 276 282
45. Hjalgrim H., Smedby K. E., Rostgaard K., Molin D., Hamilton-Dutoit S., Chang E. T., Ralfkiaer E., Sundstrm C., Adami H.-O., Glimelius B., Melbye M., Infectious mononucleosis, childhood social environment, and risk of Hodgkin lymphoma Cancer Research 2007 67 5 2382 2388
46. Kppers R., Molecular biology of Hodgkin lymphoma Hematology 2009 491 496
47. Kilger E., Kieser A., Baumann M., Hammerschmidt W., Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor EMBO Journal 1998 17 6 1700 1709
48. Mancao C., Hammerschmidt W., Epstein-Barr virus latent membrane protein 2A is a B-cell receptor mimic and essential for B-cell survival Blood 2007 110 10 3715 3721
49. Bruninger A., Schmitz R., Bechtel D., Renn C., Hansmann M.-L., Kppers R., Molecular biology of Hodgkin's and Reed/Sternberg cells in Hodgkin's lymphoma International Journal of Cancer 2006 118 8 1853 1861
50. Bechtel D., Kurth J., Unkel C., Kppers R., Transformation of BCR-deficient germinal-center B cells by EBV supports a major role of the virus in the pathogenesis of Hodgkin and posttransplantation lymphomas Blood 2005 106 13 4345 4350
51. Chaganti S., Bell A. I., Pastor N. B., Milner A. E., Drayson M., Gordon J., Rickinson A. B., Epstein-Barr virus infection in vitro can rescue germinal center B cells with inactivated immunoglobulin genes Blood 2005 106 13 4249 4252
52. Schmitz R., Hansmann M.-L., Bohle V., Martin-Subero J. I., Hartmann S., Mechtersheimer G., Klapper W., Vater I., Giefing M., Gesk S., Stanelle J., Siebert R., Kppers R., TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma Journal of Experimental Medicine 2009 206 5 981 989
53. Keegan T. H. M., Glaser S. L., Clarke C. A., Gulley M. L., Craig F. E., DiGiuseppe J. A., Dorfman R. F., Mann R. B., Ambinder R. F., Epstein-Barr virus as a marker of survival after Hodgkin's lymphoma: a population-based study Journal of Clinical Oncology 2005 23 30 7604 7613
54. Biggar R. J., Jaffe E. S., Goedert J. J., Chaturvedi A., Pfeiffer R., Engels E. A., Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS Blood 2006 108 12 3786 3791
55. Chetaille B., Bertucci F., Finetti P., Esterni B., Stamatoullas A., Picquenot J. M., Copin M. C., Morschhauser F., Casasnovas O., Petrella T., Molina T., Vekhoff A., Feugier P., Bouabdallah R., Birnbaum D., Olive D., Xerri L., Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome Blood 2009 113 12 2765 2775
56. Hjalgrim H., Rostgaard K., Johnson P. C. D., Shield L., Little A.-M., Ekstrom-Smedby K., Adami H.-O., Glimelius B., Hamilton-Dutoit S., Kane E., Malcolm Taylor G., McConnachie A., Ryder L. P., Sundstrom C., Andersen P. S., Chang E. T., Alexander F. E., Melbye M., Jarrett R. F., HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma Proceedings of the National Academy of Sciences of the United States of America 2010 107 14 6400 6405
57. Shenoy P. J., Maggioncalda A., Malik N., Flowers C. R., Incidence patterns and outcomes for Hodgkin lymphoma patients in the United States. Advances in Hematology, 2010 (in press)